感染诱导的凝血酶生成:早产胎膜早破的一种潜在新机制
本研究以足月择期剖宫产获取的原代胎膜细胞及全层胎膜组织块为对象,检测微小脲原体或脂多糖暴露24小时后凝血酶原生成。结果发现微小脲原体以剂量依赖方式显著增加胎膜凝血酶原mRNA和蛋白表达,而脂多糖未引起显著增加,提示微小脲原体诱导的凝血酶原生成可能是早产胎膜早破的潜在新机制。
要点
- 微小脲原体以剂量依赖方式显著上调胎膜细胞凝血酶原mRNA和蛋白表达。
- 脂多糖暴露未显著增加胎膜凝血酶原表达。
- 胎膜羊膜、绒毛膜和蜕膜细胞均可直接生成凝血酶原。
核心结论
- 结果显示胎膜羊膜、绒毛膜和蜕膜细胞可直接生成凝血酶原,且微小脲原体暴露可刺激胎膜凝血酶原生成,代表微小脲原体诱导胎膜破裂的潜在新机制。
研究设计与样本
- 研究获取足月、无并发症择期剖宫产的原代胎膜细胞(羊膜上皮、绒毛膜滋养层和蜕膜基质细胞)或全层胎膜组织块。
- 细胞或组织块以活微小脲原体(1×10^5、1×10^6或1×10^7 CFU/mL)或脂多糖(大肠埃希菌J5,100 ng/mL或1000 ng/mL)感染24小时。
- 采用蛋白质印迹或定量逆转录聚合酶链反应分别定量凝血酶原蛋白或mRNA生成,数据以均值±标准误表示,采用单因素方差分析及Dunnett事后检验。
主要发现
- 蛋白质印迹和免疫染色在所有原代胎膜细胞和组织块中证实凝血酶原生成与定位,羊膜上皮细胞呈核周定位,绒毛膜和蜕膜细胞呈核周和胞质定位。
- 微小脲原体1×10^7 CFU/mL显著增加凝血酶原mRNA(倍数变化:羊膜4.1±1.9;绒毛膜5.7±4.2;蜕膜10.0±5.4;胎膜9.2±3.0)和蛋白表达(倍数变化:羊膜138.0±44.0;绒毛膜139.6±15.1;蜕膜56.9±29.1;胎膜133.1±40.0),与未处理对照相比。
- 微小脲原体1×10^6 CFU/mL显著上调绒毛膜细胞凝血酶原蛋白表达(倍数变化54.9±5.3)和蜕膜细胞凝血酶原mRNA表达(倍数变化4.4±1.9)。
- 脂多糖处理未显著增加胎膜凝血酶原mRNA和蛋白表达。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preterm premature rupture of membranes is a leading contributor to maternal and neonatal morbidity and death. Epidemiologic and experimental studies have demonstrated that thrombin causes fetal membrane weakening and subsequently preterm premature rupture of membranes. Although blood is suspected to be the likely source of thrombin in fetal membranes and amniotic fluid of patients with preterm premature rupture of membranes, this has not been proved. Ureaplasma parvum is emerging as a pathogen involved in prematurity, which includes preterm premature rupture of membranes; however, until now, prothrombin production that has been induced directly by bacteria in fetal membranes has not been described. OBJECTIVE: This study was designed to investigate whether Ureaplasma parvum exposure can induce prothrombin production in fetal membranes cells. STUDY DESIGN: Primary fetal membrane cells (amnion epithelial, chorion trophoblast, and decidua stromal) or full-thickness fetal membrane tissue explants from elective, term, uncomplicated cesarean deliveries were harvested. Cells or tissue explants were infected with live Ureaplasma parvum (1×105, 1×106 or 1×107 colony-forming units per milliliter) or lipopolysaccharide (Escherichia coli J5, L-5014; Sigma Chemical Company, St. Louis, MO; 100 ng/mL or 1000 ng/mL) for 24 hours. Tissue explants were fixed for immunohistochemistry staining of thrombin/prothrombin. Fetal membrane cells were fixed for confocal immunofluorescent staining of the biomarkers of fetal membrane cell types and thrombin/prothrombin. Protein and messenger RNA were harvested from the cells and tissue explants for Western blot or quantitative reverse transcription polymerase chain reaction to quantify thrombin/prothrombin protein or messenger RNA production, respectively. Data are presented as mean values ± standard errors of mean. Data were analyzed using 1-way analysis of variance with post hoc Dunnett's test. RESULTS: Prothrombin production and localization were confirmed by Western blot and immunostainings in all primary fetal membrane cells and tissue explants. Immunofluorescence observations revealed a perinuclear localization of prothrombin in amnion epithelial cells. Localization of prothrombin in chorion and decidua cells was perinuclear and cytoplasmic. Prothrombin messenger RNA and protein expression in fetal membranes were increased significantly by Ureaplasma parvum, but not lipopolysaccharide, treatments in a dose-dependent manner. Specifically, Ureaplasma parvum at a dose of 1×107 colony-forming units/mL significantly increased both prothrombin messenger RNA (fold changes in amnion: 4.1±1.9; chorion: 5.7±4.2; decidua: 10.0±5.4; fetal membrane: 9.2±3.0) and protein expression (fold changes in amnion: 138.0±44.0; chorion: 139.6±15.1; decidua: 56.9±29.1; fetal membrane: 133.1±40.0) compared with untreated control subjects. Ureaplasma parvum at a dose of 1×106 colony-forming units/mL significantly up-regulated prothrombin protein expression in chorion cells (fold change: 54.9±5.3) and prothrombin messenger RNA expression in decidua cells (fold change: 4.4±1.9). CONCLUSION: Our results demonstrate that prothrombin can be produced directly by fetal membrane amnion, chorion, and decidua cells. Further, prothrombin production can be stimulated by Ureaplasma parvum exposure in fetal membranes. These findings represent a potential novel underlying mechanism of Ureaplasma parvum-induced rupture of fetal membranes.
引用
- Feng L, Allen TK, Marinello WP, et al. Infection-induced thrombin production: a potential novel mechanism for preterm premature rupture of membranes (PPROM). Am J Obstet Gynecol. 2018. PMID: 29660299. doi:10.1016/j.ajog.2018.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。